• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患者对肺癌和结直肠癌全身 MRI 或常规分期方法的偏好:一项离散选择实验。

Patient preferences for whole-body MRI or conventional staging pathways in lung and colorectal cancer: a discrete choice experiment.

机构信息

Department of Psychological Sciences, Birkbeck, University of London, Malet Street, London, WC1E 7HX, UK.

Centre for Medical Imaging, University College London, Charles Bell House, 43-45 Foley Street, London, W1W 7TS, UK.

出版信息

Eur Radiol. 2019 Jul;29(7):3889-3900. doi: 10.1007/s00330-019-06153-4. Epub 2019 Apr 1.

DOI:10.1007/s00330-019-06153-4
PMID:30937589
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6554244/
Abstract

OBJECTIVES

To determine the importance placed by patients on attributes associated with whole-body MRI (WB-MRI) and standard cancer staging pathways and ascertain drivers of preference.

METHODS

Patients recruited to two multi-centre diagnostic accuracy trials comparing WB-MRI with standard staging pathways in lung and colorectal cancer were invited to complete a discrete choice experiment (DCE), choosing between a series of alternate pathways in which 6 attributes (accuracy, time to diagnosis, scan duration, whole-body enclosure, radiation exposure, total scan number) were varied systematically. Data were analysed using a conditional logit regression model and marginal rates of substitution computed. The relative importance of each attribute and probabilities of choosing WB-MRI-based pathways were estimated.

RESULTS

A total of 138 patients (mean age 65, 61% male, lung n = 72, colorectal n = 66) participated (May 2015 to September 2016). Lung cancer patients valued time to diagnosis most highly, followed by accuracy, radiation exposure, number of scans, and time in the scanner. Colorectal cancer patients valued accuracy most highly, followed by time to diagnosis, radiation exposure, and number of scans. Patients were willing to wait 0.29 (lung) and 0.45 (colorectal) weeks for a 1% increase in pathway accuracy. Patients preferred WB-MRI-based pathways (probability 0.64 [lung], 0.66 [colorectal]) if they were equivalent in accuracy, total scan number, and time to diagnosis compared with a standard staging pathway.

CONCLUSIONS

Staging pathways based on first-line WB-MRI are preferred by the majority of patients if they at least match standard pathways for diagnostic accuracy, time to diagnosis, and total scan number.

KEY POINTS

• WB-MRI staging pathways are preferred to standard pathways by the majority of patients provided they at least match standard staging pathways for accuracy, total scan number, and time to diagnosis. • For patients with lung cancer, time to diagnosis was the attribute valued most highly, followed by accuracy, radiation dose, number of additional scans, and time in a scanner. Preference for patients with colorectal cancer was similar. • Most (63%) patients were willing to trade attributes, such as faster diagnosis, for improvements in pathway accuracy and reduced radiation exposure.

摘要

目的

确定患者对全身磁共振成像(WB-MRI)和标准癌症分期途径相关属性的重视程度,并确定偏好的驱动因素。

方法

招募参加两项多中心诊断准确性试验的患者,这些试验比较了 WB-MRI 与肺癌和结直肠癌的标准分期途径,邀请他们完成离散选择实验(DCE),在一系列交替途径中进行选择,其中 6 个属性(准确性、诊断时间、扫描持续时间、全身包围、辐射暴露、总扫描次数)系统变化。使用条件逻辑回归模型分析数据,并计算边际替代率。估计每个属性的相对重要性和选择基于 WB-MRI 的途径的概率。

结果

共有 138 名患者(平均年龄 65 岁,61%为男性,肺癌 72 例,结直肠癌 66 例)参与了研究(2015 年 5 月至 2016 年 9 月)。肺癌患者最看重诊断时间,其次是准确性、辐射暴露、扫描次数和扫描时间。结直肠癌患者最看重准确性,其次是诊断时间、辐射暴露和扫描次数。患者愿意等待 0.29 周(肺癌)和 0.45 周(结直肠癌),以获得 1%的途径准确性提高。如果基于 WB-MRI 的途径在准确性、总扫描次数和诊断时间方面与标准分期途径相当,患者更倾向于选择基于 WB-MRI 的途径(肺癌概率为 0.64,结直肠癌概率为 0.66)。

结论

如果基于一线 WB-MRI 的分期途径在诊断准确性、诊断时间和总扫描次数方面至少与标准途径相当,那么大多数患者更倾向于选择这些途径。

关键点

  1. 基于 WB-MRI 的分期途径在大多数患者中优于标准途径,前提是它们在准确性、总扫描次数和诊断时间方面至少与标准分期途径相当。

  2. 对于肺癌患者,诊断时间是最受重视的属性,其次是准确性、辐射剂量、额外扫描次数和扫描时间。结直肠癌患者的偏好相似。

  3. 大多数(63%)患者愿意交换属性,例如更快的诊断,以换取途径准确性的提高和辐射暴露的降低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd88/6554244/abc25f4cd7fe/330_2019_6153_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd88/6554244/77c845be9397/330_2019_6153_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd88/6554244/24fb9c0920c4/330_2019_6153_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd88/6554244/e56e7cd2e87a/330_2019_6153_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd88/6554244/abc25f4cd7fe/330_2019_6153_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd88/6554244/77c845be9397/330_2019_6153_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd88/6554244/24fb9c0920c4/330_2019_6153_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd88/6554244/e56e7cd2e87a/330_2019_6153_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd88/6554244/abc25f4cd7fe/330_2019_6153_Fig4_HTML.jpg

相似文献

1
Patient preferences for whole-body MRI or conventional staging pathways in lung and colorectal cancer: a discrete choice experiment.患者对肺癌和结直肠癌全身 MRI 或常规分期方法的偏好:一项离散选择实验。
Eur Radiol. 2019 Jul;29(7):3889-3900. doi: 10.1007/s00330-019-06153-4. Epub 2019 Apr 1.
2
Predictors of patient preference for either whole body magnetic resonance imaging (WB-MRI) or CT/ PET-CT for staging colorectal or lung cancer.预测患者对全身磁共振成像(WB-MRI)或 CT/PET-CT 用于结直肠癌或肺癌分期的偏好的因素。
J Med Imaging Radiat Oncol. 2020 Aug;64(4):537-545. doi: 10.1111/1754-9485.13038. Epub 2020 May 14.
3
Streamlining staging of lung and colorectal cancer with whole body MRI; study protocols for two multicentre, non-randomised, single-arm, prospective diagnostic accuracy studies (Streamline C and Streamline L).利用全身MRI简化肺癌和结直肠癌分期;两项多中心、非随机、单臂、前瞻性诊断准确性研究(Streamline C和Streamline L)的研究方案
BMC Cancer. 2017 May 2;17(1):299. doi: 10.1186/s12885-017-3281-x.
4
Whole-body MRI compared with standard pathways for staging metastatic disease in lung and colorectal cancer: the Streamline diagnostic accuracy studies.全身 MRI 与标准方法在肺癌和结直肠癌转移疾病分期中的比较:Streamline 诊断准确性研究。
Health Technol Assess. 2019 Dec;23(66):1-270. doi: 10.3310/hta23660.
5
Perceived patient burden and acceptability of whole body MRI for staging lung and colorectal cancer; comparison with standard staging investigations.肺癌和结直肠癌分期中患者对全身MRI的感知负担及可接受性;与标准分期检查的比较
Br J Radiol. 2018 Jun;91(1086):20170731. doi: 10.1259/bjr.20170731. Epub 2018 Mar 20.
6
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trial.全身 MRI 与标准影像学通路在新诊断非小细胞肺癌转移疾病中的诊断准确性:前瞻性 Streamline L 试验。
Lancet Respir Med. 2019 Jun;7(6):523-532. doi: 10.1016/S2213-2600(19)30090-6. Epub 2019 May 9.
7
Patient experience and perceived acceptability of whole-body magnetic resonance imaging for staging colorectal and lung cancer compared with current staging scans: a qualitative study.与当前分期扫描相比,全身磁共振成像用于结直肠癌和肺癌分期的患者体验及感知可接受性:一项定性研究
BMJ Open. 2017 Sep 6;7(9):e016391. doi: 10.1136/bmjopen-2017-016391.
8
18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis.18F-FDG PET/CT 和全身 MRI 在非小细胞肺癌 M 分期中的诊断性能:系统评价和荟萃分析。
Eur Radiol. 2020 Jul;30(7):3641-3649. doi: 10.1007/s00330-020-06703-1. Epub 2020 Mar 3.
9
Patient deprivation and perceived scan burden negatively impact the quality of whole-body MRI.患者的被剥夺感和感知到的扫描负担会对全身MRI的质量产生负面影响。
Clin Radiol. 2020 Apr;75(4):308-315. doi: 10.1016/j.crad.2019.10.019. Epub 2019 Dec 11.
10
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial.新发结直肠癌转移病灶的全身 MRI 与标准影像学检测路径的诊断准确性:前瞻性 Streamline C 试验
Lancet Gastroenterol Hepatol. 2019 Jul;4(7):529-537. doi: 10.1016/S2468-1253(19)30056-1. Epub 2019 May 9.

引用本文的文献

1
The Evolving Landscape of Discrete Choice Experiments in Health Economics: A Systematic Review.健康经济学中离散选择实验的发展态势:一项系统综述
Pharmacoeconomics. 2025 May 21. doi: 10.1007/s40273-025-01495-y.
2
Present and future of whole-body MRI in metastatic disease and myeloma: how and why you will do it.全身 MRI 在转移疾病和骨髓瘤中的现状与未来:如何以及为何您将使用它。
Skeletal Radiol. 2024 Sep;53(9):1815-1831. doi: 10.1007/s00256-024-04723-2. Epub 2024 Jul 15.
3
Patient Preferences in Diagnostic Imaging: A Scoping Review.诊断成像中的患者偏好:一项范围综述

本文引用的文献

1
Perceived patient burden and acceptability of whole body MRI for staging lung and colorectal cancer; comparison with standard staging investigations.肺癌和结直肠癌分期中患者对全身MRI的感知负担及可接受性;与标准分期检查的比较
Br J Radiol. 2018 Jun;91(1086):20170731. doi: 10.1259/bjr.20170731. Epub 2018 Mar 20.
2
Discrete-choice experiment to analyse preferences for centralizing specialist cancer surgery services.离散选择实验分析集中化专科癌症手术服务的偏好。
Br J Surg. 2018 Apr;105(5):587-596. doi: 10.1002/bjs.10761. Epub 2018 Mar 7.
3
Patient experience and perceived acceptability of whole-body magnetic resonance imaging for staging colorectal and lung cancer compared with current staging scans: a qualitative study.
Patient. 2023 Nov;16(6):579-591. doi: 10.1007/s40271-023-00646-7. Epub 2023 Sep 4.
4
The Rationality to Requesting in-ward Magnetic Resonance Imaging Investigation.要求进行体内磁共振成像检查的合理性。
J Biomed Phys Eng. 2023 Aug 1;13(4):367-376. doi: 10.31661/jbpe.v0i0.2009-1192. eCollection 2023 Aug.
5
Whole-Body MRI in Musculoskeletal Oncology: A Comprehensive Review with Recommendations.全身 MRI 在肌肉骨骼肿瘤学中的应用:全面综述及推荐意见。
Radiol Imaging Cancer. 2023 May;5(3):e220107. doi: 10.1148/rycan.220107.
6
Women's priorities towards ovarian cancer testing: a best-worst scaling study.女性对卵巢癌检测的重视程度:最佳-最差标度研究。
BMJ Open. 2022 Sep 1;12(9):e061625. doi: 10.1136/bmjopen-2022-061625.
7
Magnetic Resonance Imaging Segmentation on the Basis of Boundary Tracking Algorithm in Lung Cancer Surgery.基于边界跟踪算法的肺癌手术中磁共振成像分割。
Contrast Media Mol Imaging. 2021 Nov 8;2021:1368687. doi: 10.1155/2021/1368687. eCollection 2021.
8
Prospective Evaluation of Whole-Body MRI versus FDG PET/CT for Lesion Detection in Participants with Myeloma.前瞻性评估全身 MRI 与 FDG PET/CT 对骨髓瘤患者病灶检测的价值。
Radiol Imaging Cancer. 2021 Sep;3(5):e210048. doi: 10.1148/rycan.2021210048.
9
Value Attribution in the Decision to Use of Whole Body MRI for Early Cancer Diagnosis.全身MRI用于早期癌症诊断决策中的价值归因
Diagnostics (Basel). 2021 May 28;11(6):972. doi: 10.3390/diagnostics11060972.
10
What's New for Clinical Whole-body MRI (WB-MRI) in the 21st Century.21 世纪临床全身磁共振成像(WB-MRI)的新进展。
Br J Radiol. 2020 Nov 1;93(1115):20200562. doi: 10.1259/bjr.20200562. Epub 2020 Sep 9.
与当前分期扫描相比,全身磁共振成像用于结直肠癌和肺癌分期的患者体验及感知可接受性:一项定性研究
BMJ Open. 2017 Sep 6;7(9):e016391. doi: 10.1136/bmjopen-2017-016391.
4
Streamlining staging of lung and colorectal cancer with whole body MRI; study protocols for two multicentre, non-randomised, single-arm, prospective diagnostic accuracy studies (Streamline C and Streamline L).利用全身MRI简化肺癌和结直肠癌分期;两项多中心、非随机、单臂、前瞻性诊断准确性研究(Streamline C和Streamline L)的研究方案
BMC Cancer. 2017 May 2;17(1):299. doi: 10.1186/s12885-017-3281-x.
5
Diagnostic Performance of Whole-Body Diffusion-Weighted Imaging Compared to PET-CT Plus Brain MRI in Staging Clinically Resectable Lung Cancer.全身弥散加权成像与PET-CT联合脑MRI在临床可切除肺癌分期中的诊断效能比较
Asian Pac J Cancer Prev. 2016;17(6):2775-80.
6
Statistical Methods for the Analysis of Discrete Choice Experiments: A Report of the ISPOR Conjoint Analysis Good Research Practices Task Force.离散选择实验分析的统计方法:药物经济学与结果研究国际协会联合分析良好研究实践特别工作组报告
Value Health. 2016 Jun;19(4):300-15. doi: 10.1016/j.jval.2016.04.004. Epub 2016 May 12.
7
Cancer patients' preferences of care within hospitals: a systematic literature review.癌症患者在医院内的护理偏好:一项系统的文献综述。
Int J Qual Health Care. 2015 Oct;27(5):384-95. doi: 10.1093/intqhc/mzv059. Epub 2015 Aug 11.
8
Three-way Comparison of Whole-Body MR, Coregistered Whole-Body FDG PET/MR, and Integrated Whole-Body FDG PET/CT Imaging: TNM and Stage Assessment Capability for Non-Small Cell Lung Cancer Patients.全身 MRI、同机融合全身 18F-FDG PET/MR 与全身 18F-FDG PET/CT 成像的三方比较:非小细胞肺癌患者的 TNM 和分期评估能力。
Radiology. 2015 Jun;275(3):849-61. doi: 10.1148/radiol.14140936. Epub 2015 Jan 14.
9
Whole-body MRI vs. CT for staging lymphoma: patient experience.全身 MRI 与 CT 用于淋巴瘤分期:患者体验。
Eur J Radiol. 2014 Jan;83(1):163-6. doi: 10.1016/j.ejrad.2013.10.008. Epub 2013 Oct 21.
10
Comparison between whole-body MRI and Fluorine-18-Fluorodeoxyglucose PET or PET/CT in oncology: a systematic review.全身磁共振成像与氟-18-氟脱氧葡萄糖正电子发射断层显像或正电子发射断层显像/计算机断层扫描在肿瘤学中的比较:一项系统综述
Radiol Oncol. 2013 Jul 30;47(3):206-18. doi: 10.2478/raon-2013-0007.